# Developmental Funds

> **NIH NIH P30** · STANFORD UNIVERSITY · 2022 · $433,659

## Abstract

PROJECT SUMMARY
Developmental funds provide an essential resource to support the strategic initiatives of the Stanford Cancer
Institute (SCI). During the current funding period, the SCI used Developmental Funds to support innovative
research through a robust pilot project program and for the recruitment of new investigators, including a number
of senior leaders. Funds from the CCSG were leveraged by substantial institutional resources and directed
philanthropy to support both faculty recruitment and pilot projects. The pilot project program has been
significantly expanded to encompass funding for the development of multi-investigator collaborations and to
support new initiatives directed at pancreatic, lung, and women’s cancers, three areas of research that are highly
relevant to meeting the needs of our catchment area. In addition, a new seed grant program initiated in 2020 will
be dedicated to fulfilling the needs of the community. A standing committee, consisting of SCI senior leaders and
the SCI Director, participates in allocating these resources with input from the SCI program leaders and relevant
SCI members. All projects are reviewed for innovation and relevance to the SCI mission under the direction of
the Associate Directors for Basic Science and Community Outreach and Engagement, and all recommendations
for funding are provided to the SCI Director, who makes the final funding decisions.
During the current funding period, the SCI used Developmental Funds to support a total of 73 pilot awards,
amounting to $451,676. These were supplemented by $3,523,324 provided by the SCI from philanthropic or
other funding sources. This funding was spread across the seven research programs and resulted in 21 new
grants totaling $24,497,567 (including $16,058,932 from the NCI) and 53 publications (31 publications in high-
impact journals). The return on investment is 6:1. Developmental funds were also used in the recruitment of 14
new faculty members, including 6 junior faculty and 4 new Associate Directors. The SCI requests $500,000 per
year in developmental funds from the CCSG for the next funding period to be used for additional pilot awards,
faculty recruitment in SCI priority areas, and 2 new staff investigators—one who will further expand the reach of
SCI clinical trials and one who will lead a new SPORE application in lung cancer.

## Key facts

- **NIH application ID:** 10411085
- **Project number:** 2P30CA124435-14
- **Recipient organization:** STANFORD UNIVERSITY
- **Principal Investigator:** STEVEN E ARTANDI
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $433,659
- **Award type:** 2
- **Project period:** 2007-06-04 → 2027-05-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10411085

## Citation

> US National Institutes of Health, RePORTER application 10411085, Developmental Funds (2P30CA124435-14). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/10411085. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*